Rodman David Malcom

Chief Medical Officer at MLYS; Exec Vice President and CMO at ALPINE IMMUNE SCIENCES, INC.

Sold, on record
$20.1M
Dollars the filings state
Form 4 sales
37
Latest Aug 10, 2026
Form 144 notices
9
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

20
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale MLYSRoutine
    May 13, 2026 2026

    Sold 22,575 shares at $28.91 ($653k)

    Rodman David Malcom, Chief Medical Officer

    10b5-1 planSold 26.2% of holdings ($2.5M position)63,443 shares left2x usual sizeFiling

  2. 2 Form 4 sale MLYSRoutine
    May 18, 2026 +5 days

    Sold 417 shares at $27.55 ($11k)

    Rodman David Malcom, Chief Medical Officer

    10b5-1 planSold 0.7% of holdings ($1.8M position)63,443 shares left0x usual sizeFiling

  3. 3 Form 4 sale MLYSRoutine
    Jun 12, 2026 +25 days

    Sold 8,519 shares at $24.20 ($206k)

    Rodman David Malcom, Chief Medical Officer

    10b5-1 planSold 11.8% of holdings ($1.7M position)63,443 shares left0.7x usual sizeFiling

  4. 4 Form 4 sale MLYSRoutine
    Jun 17, 2026 +5 days

    Sold 14,474 shares at $24.19 ($350k)

    Rodman David Malcom, Chief Medical Officer

    10b5-1 planSold 20.2% of holdings ($1.7M position)57,095 shares left1.3x usual sizeFiling

  5. 5 Form 4 sale MLYSRoutine
    Jul 9, 2026 +22 days

    Sold 2,171 shares at $30.30 ($66k)

    Rodman David Malcom, Chief Medical Officer

    10b5-1 planSold 3.6% of holdings ($1.8M position)57,733 shares left0.2x usual sizeFiling

  6. 6 Form 4 sale MLYSRoutine
    Jul 15, 2026 +6 days

    Sold 20,407 shares at $27.28 ($557k)

    Rodman David Malcom, Chief Medical Officer

    10b5-1 planSold 28.4% of holdings ($2M position)51,384 shares left1.8x usual sizeFiling

  7. 7 Form 4 sale MLYSRoutine
    Jul 17, 2026 +2 days

    Sold 416 shares at $26.53 ($11k)

    Rodman David Malcom, Chief Medical Officer

    10b5-1 planSold 0.8% of holdings ($1.4M position)51,384 shares left0x usual sizeFiling

  8. 8 Form 4 sale MLYSRoutine
    Aug 10, 2026 +24 days

    Sold 2,170 shares at $27.09 ($59k)

    Rodman David Malcom, Chief Medical Officer

    10b5-1 planSold 4.1% of holdings ($1.5M position)51,384 shares left0.2x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (46)

Form 144 notices and Form 4 sales by Rodman David Malcom
Source
Aug 10, 2026Aug 12, 2026MLYSChief Medical OfficerForm 4 sale2,170$59k4.1%RoutineSEC
Jul 17, 2026Jul 20, 2026MLYSChief Medical OfficerForm 4 sale416$11k0.8%RoutineSEC
Jul 15, 2026Jul 15, 2026MLYSChief Medical OfficerForm 4 sale20,407$557k28.4%RoutineSEC
Jul 9, 2026Jul 10, 2026MLYSChief Medical OfficerForm 4 sale2,171$66k3.6%RoutineSEC
Jun 17, 2026Jun 17, 2026MLYSChief Medical OfficerForm 4 sale14,474$350k20.2%RoutineSEC
Jun 12, 2026Jun 12, 2026MLYSChief Medical OfficerForm 4 sale8,519$206k11.8%RoutineSEC
May 18, 2026May 19, 2026MLYSChief Medical OfficerForm 4 sale417$11k0.7%RoutineSEC
May 13, 2026May 13, 2026MLYSChief Medical OfficerForm 4 sale22,575$653k26.2%RoutineSEC
Apr 17, 2026Apr 21, 2026MLYSChief Medical OfficerForm 4 sale416$13k0.6%RoutineSEC
Apr 15, 2026Apr 15, 2026MLYSChief Medical OfficerForm 4 sale20,406$549k22.6%RoutineSEC
Apr 9, 2026Apr 13, 2026MLYSChief Medical OfficerForm 4 sale2,170$59k2.8%RoutineSEC
Mar 17, 2026Mar 17, 2026MLYSChief Medical OfficerForm 4 sale417$11k0.5%RoutineSEC
Mar 13, 2026Mar 16, 2026MLYSChief Medical OfficerForm 4 sale20,406$543k21.1%RoutineSEC
Mar 9, 2026Mar 10, 2026MLYSChief Medical OfficerForm 4 sale2,171$58k2.6%RoutineSEC
Feb 17, 2026Feb 17, 2026MLYSChief Medical OfficerForm 4 sale417$12k0.9%RoutineSEC
Feb 13, 2026Feb 13, 2026MLYSChief Medical OfficerForm 4 sale20,404$570k31.6%RoutineSEC
Feb 9, 2026Feb 11, 2026MLYSChief Medical OfficerForm 4 sale2,171$66k4.1%RoutineSEC
Jan 20, 2026Jan 20, 2026MLYSChief Medical OfficerForm 4 sale416$13k0.8%RoutineSEC
Jan 14, 2026Jan 15, 2026MLYSChief Medical OfficerForm 4 sale19,076$623k27.4%RoutineSEC
Jan 12, 2026Jan 13, 2026MLYSChief Medical OfficerForm 4 sale8,518$277k12.1%RoutineSEC
Jan 5, 2026Jan 6, 2026MLYSChief Medical OfficerForm 4 sale262,752$9.3M81.0%UnusualSEC
Oct 15, 2025Oct 15, 2025MLYSChief Medical OfficerForm 4 sale10,369$446k12.7%RoutineSEC
Sep 15, 2025Sep 16, 2025MLYSChief Medical OfficerForm 4 sale11,367$409k12.2%RoutineSEC
Aug 13, 2025Aug 14, 2025MLYSChief Medical OfficerForm 4 sale11,365$147k10.9%RoutineSEC
Jul 14, 2025Jul 15, 2025MLYSChief Medical OfficerForm 4 sale11,366$166k10.4%RoutineSEC
Jun 13, 2025Jun 16, 2025MLYSChief Medical OfficerForm 4 sale11,366$166k10.1%RoutineSEC
May 14, 2025May 15, 2025MLYSChief Medical OfficerForm 4 sale11,366$174k9.6%RoutineSEC
May 14, 2025May 14, 2025MLYSOfficerForm 144 notice11,366$174kNoticeSEC
Apr 14, 2025Apr 15, 2025MLYSChief Medical OfficerForm 4 sale11,366$165k9.2%RoutineSEC
Apr 14, 2025Apr 14, 2025MLYSOfficerForm 144 notice11,366$165kNoticeSEC
Apr 1, 2025Apr 3, 2025MLYSChief Medical OfficerForm 4 sale55,771$879k32.3%UnusualSEC
Apr 1, 2025Apr 1, 2025MLYSOfficerForm 144 notice55,771$879kNoticeSEC
Nov 11, 2024Nov 12, 2024MLYSChief Medical OfficerForm 4 sale5,026$75k3.4%RoutineSEC
Nov 11, 2024Nov 12, 2024MLYSOfficerForm 144 notice5,026$75kNoticeSEC
Nov 6, 2024Nov 8, 2024MLYSChief Medical OfficerForm 4 sale25,482$383k15.8%UnusualSEC
Nov 6, 2024Nov 6, 2024MLYSOfficerForm 144 notice25,482$383kNoticeSEC
Jul 16, 2024Jul 18, 2024MLYSChief Medical OfficerForm 4 sale525$8k0.5%RoutineSEC
Jul 16, 2024Jul 16, 2024MLYSOfficerForm 144 notice525$8kNoticeSEC
May 9, 2024May 10, 2024MLYSChief Medical OfficerForm 4 sale100$2k0.1%RoutineSEC
May 9, 2024May 9, 2024MLYSOfficerForm 144 notice100$2kNoticeSEC
Aug 11, 2023Aug 11, 2023MLYSChief Medical OfficerForm 4 sale231,716$3M100.0%UnusualSEC
Aug 11, 2023Aug 11, 2023MLYSOfficerForm 144 notice5,018$64kNoticeSEC
Aug 10, 2023Aug 10, 2023MLYSOfficerForm 144 notice226,698$3MNoticeSEC
Jan 4, 2017Jan 5, 2017ALPINE IMMUNE SCIENCES, INC.Exec Vice President and CMOForm 4 sale6,687$15k37.0%UnusualSEC
Oct 4, 2016Oct 5, 2016ALPINE IMMUNE SCIENCES, INC.Exec Vice President and CMOForm 4 sale5,820$46k32.2%UnusualSEC
Jul 5, 2016Jul 6, 2016ALPINE IMMUNE SCIENCES, INC.Exec Vice President and CMOForm 4 sale5,950$28k33.0%UnusualSEC